Vivimed Labs Limited (VIVIMEDLAB) — Announcement

· NSE 🔴 High Importance ⚠️ Negative

Vivimed Labs Limited announced the commencement of a Corporate Insolvency Resolution Process (CIRP) under the Insolvency and Bankruptcy Code, ordered by the NCLT Bengaluru Bench on 15 April 2026 (received 17 April 2026). Creditors must submit claims by 1 May 2026, with financial creditors filing electronically. The interim resolution professional is T. Narayana Swamy at VK Commerce, Bengaluru. The process is expected to conclude by 11 October 2026. This filing signals severe financial distress and potential restructuring or liquidation, directly impacting shareholder value.

📄 View Original Announcement (PDF)

About Vivimed Labs Limited (VIVIMEDLAB)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹61.27 Cr P/E: -4.4

View full VIVIMEDLAB stock details →

📡 Get AI alerts when VIVIMEDLAB files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track VIVIMEDLAB — Free

📊 More VIVIMEDLAB filings

See all VIVIMEDLAB filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

📡 Get AI alerts when VIVIMEDLAB files new disclosures

Track VIVIMEDLAB filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track VIVIMEDLAB — Free

Free account · 2 AI queries/day